Skip to main content

Table 1 Resistance rates of S. aureus isolates in nine European countries - adults 18+

From: Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureusin the community

   

Resistance rates(%)(95%confidence interval)

Country

Swabs

Isolates ofS. aureus

Azithromycin

Clindamycin

Erythromycin

Oxacillin

Penicillin

Fucidic acid

Mupirocin

Austria

3168

522 (16.5%)

12.8** (6.3-19.4)

11.1 (4.9 - 17.3)

12.6** (6.1-19.1)

1.5 (0-3.9)

64.4 (55-73.8)

1.0 (0-3.0)

0.2 (0-1.1)

Belgium

2892

552 (19.1%)

16.3 (9.1-23.5)

14.4 (7.5-21.3)

16.3 (9.1-23.5)

2.2 (0-5.1)

72.5 (63.7-81.3)

3.4 (0-7.0)

0.4 (0-1.6)

Croatia

3380

601 (17.8%)

5.8 (1.2-10.4)

5.5 (1-10)

5.8 (1.2-10.4)

2.3 (0-5.2)

75.4** (67-83.8)

0.2 (0-1.1)

0.7 (0-2.3)

France

3536

777 (22.0%)

17.5 (10.1-25.0)

14.9* (7.9-21.9)

17.1 (9.7-24.5)

1.8 (0-4.4)

74.4 (65.8-83)

4.0 (0.2-7.8)

0.1 (0-0.7)

Hungary

2883

359 (12.5%)

10.3** (4.3-16.3)

10.3** (4.3-16.3)

10.3** (4.3-16.3)

1.9 (0-4.6)

71.0** (62.1-79.9)

0.3 (0-1.4)

0.3 (0-1.4)

NL

3491

947 (27.1%)

6.9 (1.9-11.9)

5.2 (0.8-9.6)

5.5 (1.0-10.0)

1.0 (0-3.0)

68.4 (59.3-77.5)

5.2 (0.8-9.6)

0

Spain

3563

620 (17.5%)

11.5 (5.3-17.8)

9.5 (3.8-15.2)

11.0 (4.9-17.1)

1.3 (0-3.5)

86.0* (79.2-92.8)

1.1 (0-3.1)

1.6 (0-4.1)

Sweden

2859

846 (29.6%)

1.3 (0-3.5)

11.8 (5.5-18.1)

13.0 (6.4-19.6)

0

64.3* (54.9-73.7)

1.9 (0-4.6)

0

UK

3152

811 (25.7%)

8.6 (3.1-14.1)

7.5 (2.3-12.7)

8.9 (3.3-14.5)

1.6 (0-4.1)

73.4 (64.7-82.1)

7.8 (2.5-13.1)

0

  1. **Significant difference with children under p < 0.05.
  2. *Significant difference with children under p < 0.1.